Non-muscle-invasive bladder cancer (NMIBC) remains one of the most common
malignancies and is associated with considerable treatment costs. Patients with …

Purpose of Review BCG is the gold standard agent used in high-risk non-muscle-invasive
bladder cancer (NMIBC) that is amenable to bladder sparing management. However, recent …

Background Bladder cancer is the most prevalent malignancy involving the urinary system
and exhibits a markedly high recurrence rate. Therefore, reliable and noninvasive diagnostic …

An unmet need exists for patients with high‐risk non–muscle‐invasive bladder cancer for
whom bacille Calmette‐Guérin (BCG) has failed and who seek further bladder‐sparing …

Nanodiamonds (NDs) are a class of carbon nanomaterials with sizes ranging from a few nm
to micrometres. Due to their excellent physical, chemical and optical properties, they have …

Cancer immunotherapy has steadily progressed during the past decades, with checkpoint
inhibitor therapy becoming the latest and one of the most promising treatments. Despite the …

Nanodiamonds (NDs) are an emerging delivery system with a massive surface area
qualifying them for efficient loading with various drugs. However, NDs easily scavenge ions …

We previously demonstrated, for the first time, the abscopal effect of Boron Neutron Capture
Therapy (BNCT) in an ectopic model of syngeneic colon cancer in BDIX rats. Objective: The …

Silibinin is a natural phenol found in the seeds of the milk thistle plant. Recent data have
shown its effectiveness for preventing/treating bladder tumours. Therefore, in this study we …

Background Non-muscle-invasive bladder cancer (NMIBC) is treated with transurethral
resection of bladder tumor (TURBT) followed by intravesical instillation of chemotherapy or …